FDA clearance for Binax Bacterial Meningitis
go back to news archivesBinax have announced an additional cleared application for the patented Streptococcus pneumoniae Antigen Test.
The test can be used on CSF for the detection of bacterial meningitis caused by S. pneumoniae
Binax recently announced an exclusive distribution partnership with Remel Inc to provide rapid tests to hospital and clinical reference laboratories in the USA.
NOTE: This item is from our 'historic' database and
may contain information which is not up to date.
Source : Binax, Inc. [USA]
Now part of Alere, Inc View Company Information
Posted on December 15, 2001
LATEST MICROBIOLOGY NEWS
MICROBIOLOGY EVENTS
-
Navigating Nitrosamine Challenges: From Risk Assessment to Enhanced Ames Testing and Analytics
21 Jul 2025 -
IAFP 2025
27 Jul 2025 -
ADLM 2025
27 Jul 2025 -
Antimicrobial Resistance Trends in Anaerobes
30 Jul 2025 -
Food Safety Culture Workshop
9 Sep 2025 -
Who are the "Real" Spoilers in Food?
11 Sep 2025 -
CPD accredited course: Level 3 HACCP & Food Safety
15 Sep 2025 -
Culture Eats HACCP for Breakfast (free)
On-demand Webinar -
A3P International Congress 2025
7 Oct 2025 -
Microbiology Method Evaluation and Verification
16 Oct 2025